Skip to main content

Market Overview

D. Medical Receives First Payment Pursuant to Worldwide OEM Agreement for Spring Universal(TM) Detach Detect Infusion Sets


D. Medical Industries Ltd. (Nasdaq: DMED) announced today that its subsidiaries, Spring Health Solutions Ltd. and Spring Set Health Solutions Ltd. (collectively, "Spring Health"), have received the first payment pursuant to the previously reported worldwide original equipment manufacturer ("OEM") agreement (the "Agreement") with Twobiens Ltd., a leading South Korea-based supplier of diabetes treatment and drug delivery products, for the worldwide distribution of its Spring Universal™ Detach Detect Infusion Sets under Twobiens' private label.

The Agreement is for a term of three years and contains annual sales targets and minimum order quantities estimated at a total of US$ 5 Million. The first payment made by Twobiens represents one-third of the cost for customization as indicated in the Agreement.


Related Articles (DMED)

View Comments and Join the Discussion!

Posted-In: News Contracts

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at